Prenatal Exposures to Per- and Polyfluoroalkyl Substances and Epigenetic Aging in Umbilical Cord Blood: The Healthy Start Study
Overview
Authors
Affiliations
Background: Per- and polyfluoroalkyl substances (PFAS) are ubiquitous, environmentally persistent chemicals, and prenatal exposures have been associated with adverse child health outcomes. Prenatal PFAS exposure may lead to epigenetic age acceleration (EAA), defined as the discrepancy between an individual's chronologic and epigenetic or biological age.
Objectives: We estimated associations of maternal serum PFAS concentrations with EAA in umbilical cord blood DNA methylation using linear regression, and a multivariable exposure-response function of the PFAS mixture using Bayesian kernel machine regression.
Methods: Five PFAS were quantified in maternal serum (median: 27 weeks of gestation) among 577 mother-infant dyads from a prospective cohort. Cord blood DNA methylation data were assessed with the Illumina HumanMethylation450 array. EAA was calculated as the residuals from regressing gestational age on epigenetic age, calculated using a cord-blood specific epigenetic clock. Linear regression tested for associations between each maternal PFAS concentration with EAA. Bayesian kernel machine regression with hierarchical selection estimated an exposure-response function for the PFAS mixture.
Results: In single pollutant models we observed an inverse relationship between perfluorodecanoate (PFDA) and EAA (-0.148 weeks per log-unit increase, 95% CI: -0.283, -0.013). Mixture analysis with hierarchical selection between perfluoroalkyl carboxylates and sulfonates indicated the carboxylates had the highest group posterior inclusion probability (PIP), or relative importance. Within this group, PFDA had the highest conditional PIP. Univariate predictor-response functions indicated PFDA and perfluorononanoate were inversely associated with EAA, while perfluorohexane sulfonate had a positive association with EAA.
Conclusions: Maternal mid-pregnancy serum concentrations of PFDA were negatively associated with EAA in cord blood, suggesting a pathway by which prenatal PFAS exposures may affect infant development. No significant associations were observed with other PFAS. Mixture models suggested opposite directions of association between perfluoroalkyl sulfonates and carboxylates. Future studies are needed to determine the importance of neonatal EAA for later child health outcomes.
Epigenetic Clock at Birth and Childhood Blood Pressure Trajectory: A Prospective Birth Cohort Study.
Hu J, Meir A, Hong X, Wang G, Hu F, Wang X Hypertension. 2024; 81(10):e113-e124.
PMID: 39087326 PMC: 11410530. DOI: 10.1161/HYPERTENSIONAHA.124.22695.
Daredia S, Bozack A, Riddell C, Gunier R, Harley K, Bradman A JAMA Netw Open. 2024; 7(7):e2421824.
PMID: 39073821 PMC: 11287394. DOI: 10.1001/jamanetworkopen.2024.21824.
Impact of Environmental Exposures on Human Breast Milk Lipidome in Future Immune-Mediated Diseases.
Hyotylainen T, Ghaffarzadegan T, Karthikeyan B, Triplett E, Oresic M, Ludvigsson J Environ Sci Technol. 2024; 58(5):2214-2223.
PMID: 38263945 PMC: 10851438. DOI: 10.1021/acs.est.3c06269.
Ruden D, Singh A, Rappolee D Epigenomics. 2023; 15(14):741-754.
PMID: 37667910 PMC: 10503466. DOI: 10.2217/epi-2023-0224.